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Abstract: Ochratoxin A (OTA) is a nephrotoxic mycotoxin. Roasting of OTA-contaminated coffee
results in the formation of 2′R-ochratoxin A (2′R-OTA), which appears in the blood of coffee drinkers.
Human serum albumin (HSA) binds 2′R-OTA (and OTA) with high affinity; therefore, albumin may
influence the tissue uptake and elimination of ochratoxins. We aimed to investigate the binding
site of 2′R-OTA (verses OTA) in HSA and the displacing effects of site markers to explore which
molecules can interfere with its albumin-binding. Affinity of 2′R-OTA toward albumins from various
species (human, bovine, porcine and rat) was tested to evaluate the interspecies differences regarding
2′R-OTA-albumin interaction. Thermodynamic studies were performed to give a deeper insight
into the molecular background of the complex formation. Besides fluorescence spectroscopic and
modeling studies, effects of HSA, and fetal bovine serum on the cytotoxicity of 2′R-OTA and OTA
were tested in MDCK kidney cell line in order to demonstrate the influence of albumin-binding on
the cellular uptake of ochratoxins. Site markers displaced more effectively 2′R-OTA than OTA from
HSA. Fluorescence and binding constants of 2′R-OTA-albumin and OTA-albumin complexes showed
different tendencies. Albumin significantly decreased the cytotoxicity of ochratoxins. 2′R-OTA, even
at sub-toxic concentrations, increased the toxic action of OTA.
Keywords: 2′R-ochratoxin A; ochratoxin A; serum albumin; albumin-ligand interaction; species
differences; cellular toxicity
Key Contribution: Albumin complexes of 2′R-OTA and OTA show significant differences (e.g.,
fluorescence; binding constants and affinity to albumins from various species). Albumin significantly
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decreases the in vitro toxicity of 2′R-OTA and OTA in MDCK kidney cell line; furthermore; even at
sub-toxic concentrations; 2′R-OTA increases the acute cellular toxicity of OTA; both in the absence
and presence of fetal bovine serum.
1. Introduction
Ochratoxin A (OTA; Figure 1) is a widespread mycotoxin produced by Aspergillus and Penicillium
species [1]. It is present in several foods and drinks, mainly in cereals and cereal products but also in
coffee, beer, wine, spices and cocoa [2,3]. Due to its wide occurrence and high thermal stability [4,5],
eradication of OTA from the food chain seems impossible. OTA is nephrotoxic, however, other toxic
effects (e.g., carcinogenic, teratogenic and immunotoxic) have also been attributed to it. Chronic
exposure to OTA may play a role in the development of Balkan Endemic Nephropathy (BEN) [6,7].
During the roasting process of OTA-contaminated coffee, its diastereomer, 2′R-ochratoxin A (2′R-OTA,
previously called 14-(R)-OTA; Figure 1) is formed (up to 26% of OTA can isomerize to 2′R-OTA), which
has been detected in the blood of coffee drinkers [8]. Both mycotoxins appear in the circulation at the
lower ng/L range, the concentration of 2′R-OTA may be even higher compared to OTA [9]. Based on
in vitro studies, 2′R-OTA exhibits a lower acute toxicity than OTA [8,10].
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protein binding (99.8%), and long plasma elimination half-life (approximately one month) in humans 
[19,20]. The primary binding site of OTA is located in Sudlow’s Site I on HSA, where ionic interactions 
of the dianionic OTA (containing deprotonated carboxyl and phenolic hydroxyl groups) with two 
arginine moieties (R222 and R257) further stabilize the complex [21,22]. Furthermore, unusually large 
species differences in OTA-albumin interaction have been observed: The stability of OTA-HSA 
complex is approximately tenfold, and 30-fold higher respectively than the stabilities of OTA 
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a tenfold lower affinity than OTA [23]. Despite its lower affinity, the 2′R-OTA-HSA complex is very 
stable: The biding constant of this complex (K = 2 × 106 L/mol) is tenfold higher compared to citrinin-
HSA (K = 2 × 105 L/mol) or zearalenone-HSA (K = 105 L/mol) complexes [15,18,23], and 100-fold higher 
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Albumin is the most abundant plasma protein in the circulation, which maintains the oncotic
pressure of blood and has buffering, antioxidant, as well as pseudo-enzymatic functions [11].
Albumin interacts with several endogenous and exogenous molecules and may significantly affect the
pharmacokinetics/toxicokinetics of these compounds, due to modulation of their tissue distribution
and elimination [11,12]. Sudlow’s Site I (in subdomain IIA) and Site II (in subdomain IIIA) are the
major drug binding sites of human serum albumin (HSA) [11]. However, recent studies demonstrated
the important role of the Heme binding site in subdomain IB [13]. Several mycotoxins form
stable complexes with albumin, including aflatoxins, citrinin, ochratoxins, and zearalenone [14–18].
Interestingly, OTA forms a highly stable complex with HSA, leading to its extremely high plasma
protein binding (99.8%), and long plasma elimination half-life (approximately one month) in
humans [19,20]. The primary binding site of OTA is located in Sudlow’s Site I on HSA, where
ionic interactions of the dianionic OTA (containing deprotonated carboxyl and phenolic hydroxyl
groups) with two arginine moieties (R222 and R257) further stabilize the complex [21,22]. Furthermore,
unusually large species differences in OTA-albumin interaction have been observed: The stability of
OTA-HSA complex is approximately tenfold, and 30-fold higher respectively than the stabilities of OTA
complexes formed with bovine and rat albumins [6,17]. 2′R-OTA binds to HSA with approximately a
tenfold lower affinity than OTA [23]. Despite its lower affinity, the 2′R-OTA-HSA complex is very stable:
The biding constant of this complex (K = 2 × 106 L/mol) is tenfold higher compared to citrinin-HSA
(K = 2 × 105 L/mol) or zearalenone-HSA (K = 105 L/mol) complexes [15,18,23], and 100-fold higher
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than that of aflatoxin-HSA complexes [14]. Similarly to OTA, 2′R-OTA occupies the Sudlow’s Site I
as its high-affinity binding site on HSA, close to Trp-214, which allows energy transfer between HSA
and the albumin-bound 2′R-OTA molecule [23]. Since 2′R-OTA also forms very stable complexes with
albumin and albumin-binding strongly influences the toxicokinetics of OTA, the deeper understanding
of 2′R-OTA-albumin complex formation is desired.
In this study, further aspects of 2′R-OTA-albumin interactions were examined (and compared with
OTA-albumin complexation), including effects of site markers on the albumin-binding of 2′R-OTA,
thermodynamics of 2′R-OTA-HSA complex formation, species differences of its albumin binding
(human, bovine, porcine and rat albumins were tested), and influence of albumin on the acute cellular
toxicity of 2′R-OTA, in the absence and presence of the parent compound OTA. Thermodynamic
and modeling studies give a deeper insight into the physicochemical background of the complex
formation. Displacement of 2′R-OTA from albumin may strongly influence the elimination half-life
and/or tissue distribution of the mycotoxin. The effect of site markers on the albumin-binding of
2′R-OTA demonstrates which type of molecules are able to disrupt the albumin-binding of 2′R-OTA.
The significant interspecies differences regarding the elimination half-life of OTA is mainly attributed
to its different binding affinity toward albumins from various species [6,19]. Therefore, investigation of
the complex formation of 2′R-OTA with albumins from different species is reasonable. It may also help
to estimate how effectively we can extrapolate the results of animal studies to humans. Furthermore,
we aimed to test in cell experiments the hypothesis that high binding constants of 2′R-OTA-albumin
complexes result in the entrapment of 2′R-OTA in the cell medium, leading to the poor cellular uptake
and the decreased in vitro toxicity of the mycotoxin. We demonstrate that albumin significantly
alleviate the cytotoxicity of 2′R-OTA (and OTA) in MDCK cell line. Finally, we aimed to investigate the
influence of 2′R-OTA on the cytotoxicity of OTA in the absence and presence of albumin. This study
highlights, when simultaneously present 2′R-OTA with OTA, 2′R-OTA can increase the OTA-induced
loss of cell viability despite its relatively lower toxicity.
2. Results and Discussion
2.1. Binding of 2′R-OTA and OTA to HSA Based on Modeling Studies
For the deeper insight into the binding position of 2′R-OTA in HSA (compared to OTA), modeling
studies have been performed. As previous studies demonstrated, OTA is present in both monoanionic
(OTA−) and dianionic (OTA2−) forms at physiological pH [24–26]. However, in the human circulation,
OTA- is rapidly deprotonated by HSA resulting in the formation of an ion pair by its dianionic form
with two arginine moieties of HSA (R222 and R257) [21]. The deprotonation step implies structural
modifications both on HSA and the ligand molecule. Since this mechanism is a dynamic process, such
modifications cannot be reliably captured with static docking calculations. Using the apo structure
of HSA, docking calculations with AutoDock 4 resulted in relevant structural information about the
formation of OTA−-HSA complex (initial stage), while experimental analysis provides information
regarding OTA2−-HSA complex (final stage). The location of OTA binding site on albumin has
been proposed by both computational [23,27] and experimental studies [22]. Our docking calculations
focused on the previously reported binding site (Figure 2A), to investigate the differences in the binding
mode between 2′R- and 2′S-OTA diastereomers (Figure 2B). After docking calculations, multiple ranks
were obtained, but only the best ranked ligand conformation was selected for further discussions.
Based on these calculations, OTA− has the same orientation and binding conformation as the previously
observed binding mode [27]. The oxygen atoms of the carbonyl and phenolic hydroxyl groups orient
towards R257, while the carboxylic group towards amino acid R222 (Figure 3A). Interaction with
R222, as an important amino acid that stabilizes 2′R-OTA-HSA complex, has been described in a
recent computational molecular dynamics study as well [23]. A strong pi-stacking with W214 was
also observed for monoanionic and dianionic OTA (Figures 3A and 4A) and for dianionic 2′R-OTA
(Figure 4B). During the complex formation of monoanionic 2′R-OTA with HSA, pi-stacking interaction
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of 2′R-OTA− with Y150 was noticed (Figure 3B). Therefore, pi-stacking between the phenyl group and
W214 is not possible due to the switch of the phenyl group towards Y150. Therefore, the carboxylic
moiety of 2′R-OTA− also changes orientation, resulting in a weaker hydrogen bond with R222 and the
absence of the interaction with K195 (Figure 3B); the latter was proposed to be among the residues
that play an important role in stabilizing the phenyl ring [22]. The above listed differences between
initial binding conformations of 2′R- and 2′S-OTA may provide a structural basis of the differences in
experimental logK values described [23].
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Displacement of 2′R-OTA and OTA from HSA was investigated by fluorescence anisotropy in the
presence of site markers. Site markers are ligand molecules occupying known and well-characterized
binding sites in a protein (e.g., HSA). Therefore, site markers are commonly used compounds during
the investigation of protein-ligand interactions. The displacement of a ligand molecule by a site
marker demonstrates their competitive or allosteric interaction. Site markers can help to find the
binding sites of ligand molecules and highlight which molecules are able to displace the test ligand
from the protein. As it has been demonstrated, fluorescence polarization and anisotropy are suitable
techniques to follow the complex formation of ochratoxins with albumin, including the displacement
of ochratoxins from HSA by other compounds [15,23,24,28]. Site markers of Sudlow’s Site I (warfarin,
furosemide and phenylbutazone), Sudlow’s Site II (ibuprofen) and Heme binding site (methyl orange
and bilirubin) were applied to investigate their influence on the albumin-binding of ochratoxins [11,13].
In these experiments, anisotropy measurements were performed in PBS (pH 7.4), in the presence
of ochratoxins and HSA (1.0 and 1.5 µM, respectively) with and without the site markers (0–30 µM;
λex = 394 nm, λem = 447 nm). As Figure 5 demonstrates, each site marker induced stronger decrease
in the anisotropy value of 2′R-OTA compared to OTA. Fluorescence anisotropy gives information
regarding the rotational freedom of fluorophores. The decreased anisotropy values of ochratoxins
resulted from the increase of their rotational freedom, suggesting displacement of the mycotoxin from
HSA [15,28]. These results support the previous observation that 2′R-OTA binds to HSA with much
lower affinity than OTA [23]. Interestingly, each site marker induced some displacement of 2′R-OTA
from HSA. Modeling studies and the energy transfer between Trp-214 residue of HSA and ochratoxins
demonstrated that, similarly to OTA, 2′R-OTA occupies Sudlow’s Site I on HSA, as its high-affinity
binding site [23]. However, the observation that other site markers displaced 2′R-OTA (and/or OTA)
from albumin is not surprising, as these ligand molecules can allosterically modulate the complex
formation. Site markers of Sudlow’s Site I (subdomain IIA) can competitively displace ochratoxins from
albumin; however, because of the extremely high affinity of OTA towards HSA only slight displacement
occurred (Figure 5A–C). Despite the lower stability of 2′R-OTA-HSA compared to that of the OTA-HSA
complex, the binding constant of 2′R-OTA-HSA complex is very high (K ~ 2 × 106 L/mol) [23].
Warfarin and furosemide produced strong displacement of 2′R-OTA from HSA (Figure 5A,B), whereas
phenylbutazone induced a slight displacement (Figure 5C). Despite ibuprofen being one of the most
commonly applied marker of Sudlow’s Site II (subdomain IIIA), we have demonstrated that high
concentrations of ibuprofen can displace OTA from HSA [24]. Ibuprofen binds to HSA with comparable
affinity to 2′R-OTA [12,23], however, it induced only slight displacement (Figure 5D), which also
supports the allosteric nature of the interaction. Site markers of the Heme binding site (subdomain IB)
induced the most significant displacement of 2′R-OTA from HSA (Figure 5E,F). This can be explained
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by the fact that the Heme binding site is allosterically coupled with the Sudlow’s Site I [11], therefore,
it is reasonable to hypothesize that binding of methyl orange and bilirubin to subdomain IB induces
structural changes on subdomain IIA, resulting in the significant decrease in the binding affinity of
2′R-OTA toward HSA. Furthermore, methyl orange binds with much lower affinity to HSA than
bilirubin [13,29], which is also in agreement with our observation that bilirubin has stronger influence
on the albumin-binding of 2′R-OTA. These results emphasize that, besides Sudlow’s Site I ligands,
ligands of the Heme binding site can significantly interfere with the albumin-binding of ochratoxins,
which has not been reported, to the best of our knowledge.Toxins 2018, 10, x FOR PEER REVIEW  6 of 16 
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2.3. Thermodynamics of 2′R-OTA-HSA Interaction
Since thermodynamic data give a deeper insight into the nature of protein-ligand interactions
(including binding forces are involved in the complex formation) [30], the binding ability of 2′R-OTA
towards HSA was also examined at different temperatures. According to the van’t Hoff equation
(Equation (2)), the logK values expressed as the function of the appropriate reciprocal temperatures
show good linearity (Figure 6). The ∆G values suggest a non-covalent spontaneous interaction of
2′R-OTA with HSA at room-temperature (−39.04 kJ mol−1). Our results suggest that formation of
2′R-OTA-HSA complex is an entropy-driven process, where smaller enthalpy change is associated with
higher entropy gain (in agreement with the known enthalpy-entropy compensation). Furthermore,
based on the description of Ross and Subramanian [30], the negative enthalpy change with the positive
entropy change suggest the importance of electrostatic forces in stabilization of the formed complexes.Toxins 2018, 10, x FOR PEER REVIEW  7 of 16 
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Table 1. Enhancement of the fluorescence of 2′R-OTA by complex formation with albumins from
different species (human, bovine, porcine and rat).
Mycotoxin-Albumin Complex I/I0 (±SD) (λex = 394 nm, λem = 447 nm)
2′R-OTA-HSA 2.35 ± 0.07
2′R-OTA-BSA 2.48 ± 0.06
2′R-OTA-PSA 1.98 ± 0.05
2′R-OTA-RSA 2.22 ± 0.09
2.5. Binding Constants of 2′R-OTA-albumin Complexes
Considering the previously published observations that the stability of OTA-albumin complexes
show unusually large species differences [6,19], we aimed to evaluate the interaction of 2′R-OTA
with human, bovine, porcine, and rat serum albumins. To determine the binding constants (K)
of 2′R-OTA-albumin complexes, which demonstrates the stability of the formed complexes, the
fluorescence emission spectra of 2′R-OTA (1 µM) were recorded in presence of increasing albumin
concentrations (0–5 µM) in PBS (pH 7.4), using 295 nm (excitation of albumin) and 394 nm (excitation
of 2′R-OTA) excitation wavelengths. Since the binding site of 2′R-OTA is located in Sudlow’s Site
I (which is very close to the tryptophan amino acid in albumins), excitation of samples at 295 nm
results in energy transfer between albumin and ochratoxins, and consequently the selective excitation
of albumin-bound 2′R-OTA molecules [23,31]. However, excitation of the same samples at 394 nm
leads to the excitation of both free and albumin-bound 2′R-OTA [23,24]. Figure 8 demonstrates the
emission spectra and signals at both applied wavelengths. Using 295 nm as excitation wavelength, two
emission peaks with their maxima approximately at 340 and 447 nm are observed. The first peak is the
emission signal of albumin while the second peak is the fluorescence signal of albumin-bound 2′R-OTA
(Figure 8A) [23]. Using 394 nm as excitation wavelength, the gradual increase in fluorescence at 447 nm
can be observed in presence of albumins at increasing concentration (Figure 8B), due to the fluorescence
enhancement of 2′R-OTA by albumins (Figure 7A). Binding constants of 2′R-OTA-albumin complexes
were determined by the Hyperquad program, based on the fluorescence intensities measured at 447 nm
(Figure 8C,D).
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2.6. Effects of Albumin on the In Vitro Toxicity of 2′R-OTA and OTA in MDCK Cell Line
Similarly to OTA, 2′R-OTA also forms very stable complexes with albumins (Table 2). Therefore,
it was reasonable to hypothesize that the presence of albumin may decrease the 2′R-OTA-induced
toxicity in cell experiments, due to the entrapment of the mycotoxin in the cell medium by albumin.
To test the influence of albumin on the in vitro effects of ochratoxins, the acute cellular toxicity of
2′R-OTA and OTA was investigated in the absence and presence of HSA and fetal bovine serum (FBS).
MDCK kidney cells were treated with the mycotoxins at increasing concentrations (0–50 µM) for
24 h with and without 10% FBS or 40 g/L HSA. Ten percent FBS is commonly used in cell culture
media (it yields approximately 3.5 g/L final concentration of BSA) in cell experiments, whereas
approximately 40 g/L HSA circulates in the human blood. The mycotoxin-induced loss of cell
viability was evaluated based on ATP and total protein levels. As Figure 9 demonstrates, 2′R-OTA
and OTA caused dose-dependent, significant decreases in the concentration of ATP and total protein
with slightly stronger effect on ATP levels, due to the ATP depleting effects of ochratoxins [33].
Under the applied conditions, the presence of 10% FBS or 40 g/L HSA (without ochratoxins) had no
significant effect on cell viability (data not shown). In agreement with previous studies performed
with IHKE (immortalized, human kidney, epithelial) and HepG2 (hepatocellular carcinoma, human
liver, epithelial) cell lines [8,10], 2′R-OTA exhibited approximately 10 times lower cytotoxicity than
OTA. Furthermore, the presence of 10% FBS significantly decreased, while 40 g/L HSA completely
abolished the acute toxic action of ochratoxins on MDCK cells, which is in agreement with the report
of Gekle et al. [34]. The weaker effect of FBS can be attributed to the lower BSA content of the cell
medium (3.5 g/L BSA verses 40 g/L HSA). Since albumins form very stable complexes with both
2′R-OTA and OTA, albumin likely reduces the cellular uptake of these mycotoxins, resulting in their
lower cellular toxicity.
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40 g/L HSA, after 24 h incubation (* p < 0.01).
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2.7. Co-Treatment of MDCK Cells with OTA and 2′R-OTA in the Absence and Presence of FBS
Since 2′R-OTA appears in the circulation together with OTA, the toxic action of OTA in the
presence of increasing 2′R-OTA concentrations was also tested. Both mycotoxins occupy Site I as their
primary binding sites in albumin, therefore, 2′R-OTA may able to displace OTA from HSA, resulting
in the increased cellular uptake and cytotoxicity of OTA in the presence of 2′R-OTA. Because 40 g/L
HSA completely abolished the acute toxic action of ochratoxins, co-treatment of MDCK cells with OTA
and 2′R-OTA was investigated without albumin and in the presence of 10% FBS. ATP levels/well were
quantified after 24 h incubation. As ochratoxins were significantly less toxic in the presence of albumin,
lower OTA concentration (1 µM) was applied in the experiments performed without FBS compared to
the studies carried out with 10% of FBS (where 20 µM OTA was applied). As Figure 10 demonstrates,
2′R-OTA even at sub-toxic concentrations increased significantly the toxic effect of OTA both in the
absence and presence of FBS. In the presence of FBS (Figure 10B), the 2′R-OTA-induced further loss in
cell viability may be partly attributed to the displacement of OTA from albumin by 2′R-OTA. However,
the co-treatment of MDCK cells with 2′R-OTA increases the toxic effect of OTA even in the absence of
FBS (Figure 10A), suggesting that the displacement of OTA from albumin does not play a key role in
the interaction. Therefore, other toxicokinetic and/or toxicodynamic mechanism(s) may be involved.
Despite its relatively lower toxicity, when simultaneously present 2′R-OTA with OTA, 2′R-OTA can
increase the effect of OTA.
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its orientation, leading to a weaker hydrogen bond with R222 and the absence of th interaction
with K195. Site markers induced stronger isplacement of 2′R-OTA than OTA from HSA, confirming
further the lower binding affinity of 2′R-OTA toward HSA. Interestingly, not only Site I markers but he
ligands of the H me binding sit (m thyl orange and bilirubin) also strongly d splaced 2′R-OTA from
HSA. Based on thermodynamic studies, the fo atio of 2′R-OTA-HSA complex is an entropy-driven
process, where electrostatic forces play an important role in the stabilization of the 2′R-OTA-albumin
complexes. The fluorescence enhancement of 2′R-OTA and OTA by albumins from different species
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(human, bovine, porcine and rat) showed different tendencies: 2′R-OTA showed the highest emission
signal with BSA while OTA exhibited the highest fluorescence with RSA. Despite the significant
interspecies differences in the albumin-binding of OTA (human > bovine > porcine > rat) [17,32],
the stability of 2′R-OTA-albumin complexes is similar. Similarly to OTA [34], the complex formation
of 2′R-OTA with albumins alleviates or even abolishes the acute cellular toxicity of the mycotoxin,
likely due to the decreased toxin uptake of MDCK cells. Despite its relatively low toxicity, even
sub-toxic concentrations of 2′R-OTA can increase significantly the OTA-induced loss of cell viability,
both in the absence and presence of fetal bovine serum. Therefore, these results also underline the
high importance of mycotoxin co-exposure. Finally, we need to mention some limitations of our
in vitro results. As it was concluded previously, albumin-binding of 2′R-OTA alone does not explain its
longer plasma elimination half-life compared to OTA [23]. Furthermore, the toxicological consequence
of OTA-albumin interaction is a controversial issue. The significant albumin-binding may limit the
cellular uptake of OTA (even in vivo), which can be a protective mechanism. However, the complex
formation of OTA with albumin also inhibits the rapid glomerular filtration of OTA (which would
be an efficient elimination mechanism in the absence of albumin) [6]. Therefore, further in vivo
experiments are necessary in the future to explore the toxicological outcome of 2′R-OTA-albumin and
OTA-albumin interactions.
4. Materials and Methods
4.1. Reagents
2′R-ochratoxin A (2′R-OTA) was synthetized as described [23]. Ochratoxin A (OTA), human serum
albumin (HSA), bovine serum albumin (BSA), porcine serum albumin (PSA), rat serum albumin (RSA),
racemic warfarin, furosemide, phenylbutazone, ibuprofen, methyl orange, bilirubin, and Dulbecco’s
Modified Eagle Medium (DMEM) were obtained from Sigma-Aldrich (Saint Louis, MO, USA). Fetal
bovine serum (FBS), (Pan-Biotech, Aidenbach, Germany), Bioluminescent ATP Assay Kit CLSII (Roche;
Basel, Switzerland), and Coomassie Brilliant Blue G-250 (Reanal; Budapest, Hungary) were used as
received. Stock solutions of 2′R-OTA and OTA (both 5000 µM) were prepared in ethanol (96 v/v%,
Reanal, spectroscopic grade) and stored protected from light at −20 ◦C.
4.2. Modeling Studies
Mycotoxin molecules were built in Maestro [35]. The raw structures were energy minimized,
employing the semi-empirical quantum chemistry program package, MOPAC [36], and PM6
parameterization [37]. The gradient norm was set to 0.001. The energy minimized structure was
subjected to force calculations. The force constant matrices were positive definite. The minimized
ligand structures were inputs of our docking calculations.
During the calculations, an apo crystallographic structure of HSA (PDB code: 1ao6) was used.
Schrödinger Maestro program package v. 9.6 [35] was applied for the attachment of acetyl and amide
capping groups to the N- and C-termini, respectively. As 1ao6 contains a homodimer structure,
only chain A was used for calculations. Co-crystallized ions and water molecules were removed
before minimizing the protein structure. A two-step protocol was applied using GROMACS software
package [38], including a steepest descent and a conjugate gradient step, and using AMBER99-ildn
force field [39]. Exit tolerance levels were set to 1000 and 10 kJ mol−1 nm−1 while maximum step
sizes were set to 0.5 and 0.05 nm, respectively. The minimized target structure was the input of our
docking calculations.
Using the optimized ligand and target structures, docking calculations were carried out with
AutoDock 4.2 program [40] as described elsewhere [15,41–43]. Gasteiger-Marsilli partial charges were
added to both the ligand and target atoms, using AutoDock Tools [40] and a united atom representation
was applied for non-polar hydrogens. A grid box of 90 × 90 × 90 points, and 0.375 Å spacing was
calculated and centered on Sudlow’s Site I pocket in AutoGrid 4. Lamarckian genetic algorithm was
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applied for global search. Flexibility was allowed on the ligand at all active torsions, number of docking
runs was set to 100, numbers of energy evaluations and generations were 20 million [42]. Docked
ligand conformations were ordered by the corresponding calculated interaction energy values and
subsequently clustered using a tolerance of 1.75 Å root mean square deviation (RMSD) between cluster
members [41]. Conformations of the lowest energy of a cluster were selected as cluster representatives
were further analyzed.
4.3. Fluorescence Spectroscopic Studies
Fluorescence spectroscopic analyses, including anisotropy measurements, were carried out
employing a Hitachi F-4500 fluorescence spectrophotometer. Spectroscopic measurements were
performed in phosphate buffered saline (PBS, pH 7.4) at 25 ◦C in the presence of air. Fluorescence
emission spectrum of 2′R-OTA (1 µM) was recorded in the presence of increasing concentrations of
albumin (0.0, 0.1, 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 2.0, 3.0 and 5.0 µM) using 295 and 394 nm as excitation
wavelengths. At 394 nm, we excited directly 2′R-OTA and its albumin complex [23]. However, using
295 nm excitation wavelength, albumin-bound 2′R-OTA was excited as a result of the energy transfer
between albumins and 2′R-OTA [23,31].
Binding constants (K) of mycotoxin-albumin complexes were calculated by non-linear
fitting, using the Hyperquad2006 program package (Protonic Software) as described in previous
studies [23,44–46]. The stoichiometry of 2′R-OTA-albumin complexes was calculated based on the
model associated with the lowest standard deviation.
Fluorescence anisotropy measurements were performed using 394 and 447 nm excitation and
emission wavelengths, respectively. In these experiments, increasing amounts of site markers (final
concentrations: 0, 2, 5, 10, 20, and 30 µM) were added to standard mycotoxin (2′R-OTA or OTA) and
HSA concentrations (1.0 and 1.5 µM, respectively) in PBS. Fluorescence anisotropy were calculated
using the following Equation:
r =
(IVV − G× IVH)
(IVV + 2× G× IVH) (1)
where r and G denote the fluorescence anisotropy and the instrumental correction factor, respectively.
IVV and IVH represent fluorescence emission intensities determined in vertical position of polarizer at
pre-sample site and at vertical and horizontal position of post-sample polarizer, respectively.
4.4. Thermodynamic Studies
For the deeper insight into 2′R-OTA-HSA interaction, binding constants of mycotoxin-albumin
complexes were also determined at six different temperatures (298, 301, 304, 307, 310 and 313 K).
The binding constants were determined by the Hyperquad2006 program package [23,44–46], using
394 and 447 nm as excitation and emission wavelengths, respectively. Thermodynamic parameters
associated to the complex formation between 2′R-OTA and HSA were determined based on the van ’t
Hoff equation:
logK = −∆G
RT
= − ∆H
2.303RT
+
∆S
2.303R
(2)
where ∆G, ∆H, and ∆S denote the Gibbs free energy, enthalpy, and entropy changes of the binding
reaction, respectively; while R is the gas constant and T refers the temperature.
4.5. Cell Culturing and Cell Viability Assay
MDCK (Madin-Darby canine kidney epithelial cell line, ATCC: CCL-34) cell culture was
maintained in DMEM with 10% FBS, penicillin (100 U/mL), and streptomycin (100 µg/mL) at 37 ◦C
in a humidified environment (5% CO2). Cells were trypsinized and plated in 96-well sterile plastic
plates (approximately 104 cells/well) for overnight pre-incubation. Next day, the culture medium
was replaced with fresh one (with or without 10% FBS or 40 g/L HSA), then cells were treated with
increasing concentrations of 2′R-OTA and/or OTA (0, 1, 5, 10, 20 and 50 µM; in 150 µL medium/well).
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After 24 h incubation, cell viability was evaluated based on cellular ATP and total protein levels.
Analyses of ATP and total protein concentrations/well were performed based on the luciferin-luciferase
and Bradford reactions, respectively, during which the previously published method was applied
without modifications [47].
4.6. Statistics
Figures demonstrate the means and standard error (SEM) values based on at least three
independent experiments. Data were analyzed using one-way ANOVA test with p < 0.01, as the
level of significance (IBM SPSS Statistics software 2012, version 21, New York, NY, USA).
Author Contributions: M.P., Z.F., F.S., B.C., and H.-U.H conceived the study and wrote the paper. Z.F. and M.P.
performed fluorescence spectroscopic investigations. D.D. and B.L. carried out thermodynamic studies. B.L. and
S.K.-M. determined binding constants employing the Hyperquad program. M.B. and C.H. performed molecular
modeling studies. R.C. and T.K. carried out cell experiments. All authors have read, edited, and approved the
final version of the paper.
Funding: This study was supported by the Hungarian National Research, Development and Innovation Office
(FK125166) and the Deutsche Forschungsgemeinschaft, Bonn, Germany (HU 730/10-2). The work of M.B. and
C.H. is supported by the Hungarian National Research, Development and Innovation Office (K123836).
Acknowledgments: This project was supported by the János Bolyai Research Scholarship of the Hungarian
Academy of Sciences (M.P.). M.P. is thankful for support of the University of Pécs for the grant in the frame of
“Pharmaceutical Talent” Centre program. We acknowledge a grant of computer time from CSCS Swiss National
Supercomputing Centre, and NIIF Hungarian National Information Infrastructure Development Institute. We
acknowledge that the results of this research have been achieved using the DECI resource Archer based in the UK
at the National Supercomputing Service with support from the PRACE aisbl. M.B. and C.H. are thankful to the
University of Pécs for the grant in the frame of “Supporting Individual Research and Innovation Activity of Young
Researchers, 2018” program. Financial support of the GINOP-2.3.2-15-2016-00049 grant is highly appreciated
(S.K.-M.).
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Wang, Y.; Wang, L.; Liu, F.; Wang, Q.; Selvaraj, J.N.; Xing, F.; Zhao, Y.; Liu, Y. Ochratoxin A producing fungi,
biosynthetic pathway and regulatory mechanisms. Toxins 2016, 8, 83. [CrossRef] [PubMed]
2. el Khoury, A.; Atoui, A. Ochratoxin A: general overview and actual molecular status. Toxins 2010, 2, 461–493.
[CrossRef] [PubMed]
3. Duarte, S.C.; Pena, A.; Lino, C.M. A review on ochratoxin A occurrence and effects of processing of cereal
and cereal derived food products. Food Microbiol. 2010, 27, 187–198. [CrossRef] [PubMed]
4. Trivedi, A.B.; Doi, E.; Kitabatake, N. Detoxification of ochratoxin A on heating under acidic and alkaline
conditions. Biosci. Biotech. Biochem. 1992, 56, 741–745. [CrossRef] [PubMed]
5. Vidal, A.; Sanchis, V.; Ramos, A.J.; Marín, S. Thermal stability and kinetics of degradation of deoxynivalenol,
deoxynivalenol conjugates and ochratoxin A during baking of wheat bakery products. Food Chem. 2015, 178,
276–286. [CrossRef] [PubMed]
6. Ko˝szegi, T.; Poór, M. Ochratoxin A: molecular interactions, mechanisms of toxicity and prevention at the
molecular level. Toxins 2016, 8, 111. [CrossRef] [PubMed]
7. Malir, F.; Ostry, V.; Pfohl-Leszkowicz, A.; Malir, J.; Toman, J. Ochratoxin A: 50 years of research. Toxins 2016,
8, 191. [CrossRef] [PubMed]
8. Cramer, B.; Königs, M.; Humpf, H.-U. Identification and in vitro cytotoxicity of ochratoxin A degradation
products formed during coffee roasting. J. Agric. Food. Chem. 2008, 56, 5673–5681. [CrossRef] [PubMed]
9. Cramer, B.; Osteresch, B.; Muñoz, K.A.; Hillmann, H.; Sibrowski, W.; Humpf, H.-U. Biomonitoring using
dried blood spots: Detection of ochratoxin A and its degradation product 2′R-ochratoxin A in blood from
coffee drinkers. Mol. Nutr. Food Res. 2015, 59, 1837–1843. [CrossRef] [PubMed]
10. Cramer, B.; Harrer, H.; Nakamura, K.; Uemura, D.; Humpf, H.-U. Total synthesis and cytotoxicity evaluation
of all ochratoxin A stereoisomers. Bioorg. Med. Chem. 2010, 18, 343–347. [CrossRef] [PubMed]
11. Fanali, G.; di Masi, A.; Trezza, V.; Marino, M.; Fasano, M.; Ascenzi, P. Human serum albumin: from bench to
bedside. Mol. Aspects Med. 2012, 33, 209–290. [CrossRef] [PubMed]
Toxins 2018, 10, 353 15 of 16
12. Yamasaki, K.; Chuang, V.T.; Maruyama, T.; Otagiri, M. Albumin-drug interaction and its clinical implication.
Biochim. Biophys. Acta. 2013, 1830, 5435–5443. [CrossRef] [PubMed]
13. Zsila, F. Subdomain IB is the third major drug binding region of human serum albumin: Toward the
Three-Sites Model. Mol. Pharm. 2013, 10, 1668–1682. [CrossRef] [PubMed]
14. Poór, M.; Bálint, M.; Hetényi, C.; Go˝dér, B.; Kunsági-Máté, S.; Ko˝szegi, T.; Lemli, B. Investigation of
non-covalent interactions of aflatoxins (B1, B2, G1, G2, and M1) with serum albumin. Toxins 2017, 9, 339.
[CrossRef] [PubMed]
15. Poór, M.; Lemli, B.; Bálint, M.; Hetényi, C.; Sali, N.; Ko˝szegi, T.; Kunsági-Máté, S. Interaction of citrinin with
human serum albumin. Toxins 2015, 7, 5155–5166. [CrossRef] [PubMed]
16. Perry, J.L.; Il’ichev, Y.V.; Kempf, V.R.; McClendon, J.; Park, G.; Manderville, R.A.; Rüker, F.; Dockal, M.;
Simon, J.D. Binding of ochratoxin A derivatives to human serum albumin. J. Phys. Chem. B 2003, 107,
6644–6647. [CrossRef]
17. Poór, M.; Li, Y.; Matisz, G.; Kiss, L.; Kunsági-Máté, S.; Ko˝szegi, T. Quantitation of species differences in
albumin-ligand interactions for bovine, human and rat serum albumins using fluorescence spectroscopy: A
test case with some Sudlow’s site I ligands. J. Lumin. 2014, 145, 767–773. [CrossRef]
18. Poór, M.; Kunsági-Máté, S.; Bálint, M.; Hetényi, C.; Gerner, Z.; Lemli, B. Interaction of mycotoxin zearalenone
with human serum albumin. J. Photochem. Photobiol. B 2017, 170, 16–24. [CrossRef] [PubMed]
19. Hagelberg, S.; Hult, K.; Fuchs, R. Toxicokinetics of ochratoxin A in several species and its plasma-binding
properties. J. Appl. Toxicol. 1989, 9, 91–96. [CrossRef] [PubMed]
20. Studer-Rohr, I.; Schlatter, J.; Dietrich, D.R. Kinetic parameters and intraindividual fluctuations of ochratoxin
A plasma levels in humans. Arch. Toxicol. 2000, 74, 499–510. [CrossRef] [PubMed]
21. Il’ichev, Y.V.; Perry, J.L.; Simon, J.D. Interaction of ochratoxin A with human serum albumin. Preferential
binding of the dianion and pH effects. J. Phys. Chem. B 2002, 106, 452–459. [CrossRef]
22. Il’ichev, Y.V.; Perry, J.L.; Simon, J.D. Interaction of ochratoxin A with human serum albumin. A common
binding site of ochratoxin A and warfarin in subdomain IIA. J. Phys. Chem. B 2002, 106, 460–465. [CrossRef]
23. Sueck, F.; Poór, M.; Faisal, Z.; Gertzen, C.G.W.; Cramer, B.; Lemli, B.; Kunsági-Máté, S.; Gohlke, H.;
Humpf, H.-U. Interaction of ochratoxin A and its thermal degradation product 2′R-ochratoxin A with
human serum albumin. Toxins 2018, 10, 256. [CrossRef] [PubMed]
24. Poór, M.; Kunsági-Máté, S.; Czibulya, Z.; Li, Y.; Peles-Lemli, B.; Petrik, J.; Vladimir-Kneževic´, S.; Ko˝szegi, T.
Fluorescence spectroscopic investigation of competitive interactions between ochratoxin A and 13 drug
molecules for binding to human serum albumin. Luminescence 2013, 28, 726–733. [CrossRef] [PubMed]
25. Poór, M.; Kunsági-Máté, S.; Matisz, G.; Li, Y.; Czibulya, Z.; Peles-Lemli, B.; Ko˝szegi, T. Interaction of alkali
and alkaline earth ions with Ochratoxin A. J. Lumin. 2013, 135, 276–280. [CrossRef]
26. Poór, M.; Kuzma, M.; Matisz, G.; Li, Y.; Perjési, P.; Kunsági-Máté, S.; Ko˝szegi, T. Further aspects of ochratoxin
A–cation interactions: complex formation with zinc ions and a novel analytical application of ochratoxin
A–magnesium interaction in the HPLC-FLD system. Toxins 2014, 6, 1295–1307. [CrossRef] [PubMed]
27. Perry, J.L.; Goldsmith, M.R.; Peterson, M.A.; Beratan, D.N.; Wozniak, G.; Rüker, F.; Simon, J.D. Structure
of the ochratoxin A binding site within human serum albumin. J. Phys. Chem. B 2004, 108, 16960–16964.
[CrossRef]
28. Poór, M.; Kunsági-Máté, S.; Bencsik, T.; Petrik, J.; Vladimir-Kneževi´c, S.; Ko˝szegi, T. Flavonoid aglycones can
compete with ochratoxin A for human serum albumin: A new possible mode of action. Int. J. Biol. Macromol.
2012, 51, 279–283. [CrossRef] [PubMed]
29. Ahlfors, C.E. Competitive interaction of biliverdin and bilirubin only at the primary bilirubin binding site on
human albumin. Anal. Biochem. 1981, 110, 295–307. [CrossRef]
30. Ross, P.D.; Subramanian, S. Thermodynamics of protein association reactions: forces contributing to stability.
Biochemistry 1981, 20, 3096–3102. [CrossRef] [PubMed]
31. Li, Y.; Czibulya, Z.; Poór, M.; Lecomte, S.; Kiss, L.; Harte, E.; Ko˝szegi, T.; Kunsági-Máté, S. Thermodynamic
study of the effects of ethanol on the interaction of ochratoxin A with human serum albumin. J. Lumin. 2014,
148, 18–25. [CrossRef]
32. Perry, J.L.; Christensen, T.; Goldsmith, M.R.; Toone, E.J.; Beratan, D.N.; Simon, J.D. Binding of ochratoxin
A to human serum albumin stabilized by a protein-ligand ion pair. J. Phys. Chem. B 2003, 107, 7884–7888.
[CrossRef]
Toxins 2018, 10, 353 16 of 16
33. Poór, M.; Veres, B.; Jakus, P.B.; Antus, C.; Montskó, G.; Zrínyi, Z.; Vladimir-Kneževic´, S.; Petrik, J.; Ko˝szegi, T.
Flavonoid diosmetin increases ATP levels in kidney cells and relieves ATP depleting effect of ochratoxin A.
J. Photochem. Photobiol. B 2014, 132, 1–9. [CrossRef] [PubMed]
34. Gekle, M.; Pollock, C.A.; Silbernagl, S. Time- and concentration-dependent biphasic effect of ochratoxin A
on growth of proximal tubular cells in primary culture. J. Pharmacol. Exp. Ther. 1995, 275, 397–404. [PubMed]
35. Schrödinger Release 2017–4: Maestro, Schrödinger, LLC, New York, NY, USA. 2017.
36. Stewart, J.J. MOPAC: a semiempirical molecular orbital program. J. Comput. Aided. Mol. Des. 1990, 4, 1–105.
[CrossRef] [PubMed]
37. Stewart, J.J.P. Optimization of parameters for semiempirical methods V: Modification of NDDO
approximations and application to 70 elements. J. Mol. Model. 2007, 13, 1173. [CrossRef] [PubMed]
38. Abraham, M.J.; Murtola, T.; Schulz, R.; Páll, S.; Smith, J.C.; Hess, B.; Lindahl, E. GROMACS: high performance
molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 2015, 1,
19–25. [CrossRef]
39. Lindorff-Larsen, K.; Piana, S.; Palmo, K.; Maragakis, P.; Klepeis, J.L.; Dror, R.O.; Shaw, D.E. Improved
side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 2010, 78, 1950–1958. [CrossRef]
[PubMed]
40. Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and
AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 2009, 30, 2785–2791.
[CrossRef] [PubMed]
41. Hetényi, C.; van der Spoel, D. Efficient docking of peptides to proteins without prior knowledge of the
binding site. Protein Sci. 2002, 11, 1729–1737. [CrossRef] [PubMed]
42. Hetényi, C.; van der Spoel, D. Blind docking of drug-sized compounds to proteins with up to a thousand
residues. FEBS Lett. 2006, 580, 1447–1450. [CrossRef] [PubMed]
43. Hetényi, C.; van der Spoel, D. Toward prediction of functional protein pockets using blind docking and
pocket search algorithms. Protein Sci. 2011, 20, 880–893. [CrossRef] [PubMed]
44. Poór, M.; Li, Y.; Kunsági-Máté, S.; Varga, Z.; Hunyadi, A.; Dankó, B.; Chang, F.R.; Wu, Y.C.; Ko˝szegi, T.
Protoapigenone derivatives: Albumin binding properties and effects on HepG2 cells. J. Photochem. Photobiol. B
2013, 124, 20–26. [CrossRef] [PubMed]
45. Poór, M.; Boda, G.; Kunsági-Máté, S.; Needs, P.W.; Kroon, P.A.; Lemli, B. Fluorescence spectroscopic
evaluation of the interactions of quercetin, isorhamnetin, and quercetin-3′-sulfate with different albumins.
J. Lumin. 2018, 194, 156–163. [CrossRef]
46. Faisal, Z.; Lemli, B.; Szerencsés, D.; Kunsági-Máté, S.; Bálint, M.; Hetényi, C.; Kuzma, M.; Mayer, M.; Poór, M.
Interactions of zearalenone and its reduced metabolites α-zearalenol and β-zearalenol with serum albumins:
species differences, binding sites, and thermodynamics. Mycotoxin Res. 2018, in press. [CrossRef] [PubMed]
47. Sali, N.; Nagy, S.; Poór, M.; Ko˝szegi, T. Multiparametric luminescent cell viability assay in toxicology models:
A critical evaluation. J. Pharmacol. Toxicol. Methods 2016, 79, 45–54. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
